Abstract
Background
Although obesity is recognized to be a risk factor for chronic kidney disease (CKD), few studies have reported the association between obesity and CKD in the young population. We investigated the relationship between obesity and renal function including proteinuria in young Japanese.
Methods
This cross-sectional study consisted of 16,031 men and 5,746 women aged from 20 to 39 years who received health examinations. The subjects were stratified into four age groups (20–24, 25–29, 30–34, and 35–39 years) or into four groups based on the number of risk factors (hypertension, hyperglycemia, dyslipidemia, and hyperuricemia). The relationship between obesity and risk factors and the relationship between obesity and estimated glomerular filtration rate (eGFR) were analyzed.
Results
There were no significant differences in eGFR between obese and nonobese groups, except in the male 35–39 years age group. Body mass index (BMI) in both men and women increased with increase in number of risk factors (P < 0.001). Multivariate analysis revealed that hypertension, hyperglycemia, dyslipidemia, and hyperuricemia were independently associated with obesity. Obesity and the risk factors were independently associated with proteinuria.
Conclusion
The present study indicated that obesity was an independent risk factor for proteinuria in healthy subjects younger than 40 years of age. The other risk factors were independently associated with obesity. These findings suggest that obesity causes proteinuria concomitantly with other risk factors such as hypertension, diabetes, and dyslipidemia in young adults.
Similar content being viewed by others
References
National Health and Nutrition Survey: the Ministry of Health, Labor and Welfare of Japan, 2005.
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–69.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.
Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167–74.
Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–40.
Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369–74.
Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis. 2006;48:383–91.
Azegami M, Hongo M, Yanagisawa S, Yamazaki A, Sakaguchi K, Yazaki Y, et al. Characteristics of metabolic and lifestyle risk factors in young Japanese patients with coronary heart disease: a comparison with older patients. Int Heart J. 2006;47:343–50.
Azegami M, Hongo M, Yazaki Y, Yanagisawa S, Yamazaki A, Imamura H. Seasonal difference in onset of coronary heart disease in young Japanese patients: a comparison with older patients. Circ J. 2005;69:1176–9.
Horio M, Imai E, Yasuda N, Hishida A, Matsuo S. Estimation of glomerular filtration rate for Japanese. J Jpn Soc Nephrol. 2008;50:221. (in Japanese abstract).
Examination committee of criteria for diagnosis of metabolic syndrome in Japan. Definition and criteria for diagnosis of metabolic syndrome. J Jpn Soc Intern Med. 2005;94:794–809. (in Japanese with English abstract).
Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, et al. Serum uric acid concentration as a risk factor for cardiovascular mortality. J Rheumatol. 2005;32:906–12.
Examination committee of criteria for ‘obesity disease’ in Japan. Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92.
Obesity: World Health Organization. http://www.who.int/topics/obesity/en/ (2008).
Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, Baik SH, et al. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci. 2005;20:1029–33.
Cigolini M, Targher G, Tonoli M, Manara F, Muggeo M, De Sandre G. Hyperuricemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord. 1995;19:92–6.
Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, et al. Obesity-related glomerulopathy: insight from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 2006;147:44–50.
Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–509.
Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH. Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis. 2008;52:58–65.
Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278:F817–22.
Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008;26:831–43.
Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52(1):39–48.
Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871–80.
Bello AK, de Zeeuw D, El Nahas M, Brantsma AH, Bakker SJ, de Jong PE, et al. Impact of weight changes on albuminuria in the general population. Nephrol Dial Tranplant. 2007;20:1619–27.
Watanabe N, Hashimoto Y, Futamura A, Mashige F, Nakarai H, Nakahara K. Relationship between the prevalence of proteinuria and obesity in Japanese men. Rinsho Byori. 1999;47:271–4.
Tozawa M, Iseki K, Iseki C, Oshiro S, Ikeyama Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002;62:956–62.
Remuzzi G, Weening JJ. Albuminuria as early test for vascular disease. Lancet. 2005;365:556–7.
de Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int. 2004;66:2109–18.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Matsushita, K., Yasuda, G., Shouda, M. et al. Evaluation of renal function and proteinuria based on mass health examinations in young Japanese obese adults. Clin Exp Nephrol 13, 316–324 (2009). https://doi.org/10.1007/s10157-009-0164-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-009-0164-8